AAP advocates for in-school education in the fall

Article

The American Academy of Pediatrics (AAP) has strongly advocated that schools open in the fall with students being physically present.

The American Academy of Pediatrics has issued further guidance for school re-entry.1 The guidance stresses that the organization strongly urges schools to start in the fall with students being physically present.

The guidance recommends that all re-entry policies follow certain principles:

  • Policies should be flexible and nimble to better respond to new information
  • Develop strategies that can be adapted according to the level of viral transmission found in the community
  • All policies should be practical and appropriate for the students’ developmental stage.
  • Considerations and accommodations should be made for vulnerable populations of students
  • No student should be excluded from school, unless the exclusion is required to adhere to public health mandates
  • Policies should be created with the intent to support the overall health of student and families. All policies should communicated in languages other than English, as needed.
  • The guidance also provides information on physical distancing, cleaning, mental health of staff, and other considerations.

Reference

1. American Academy of Pediatrics. COVID-19 planning considerations: guidance for school re-entry. Services.aap.org. Published June 25, 2020. Accessed July 1, 2020. https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/covid-19-planning-considerations-return-to-in-person-education-in-schools/.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital
Tina Tan, MD, comments on FDA expanded approval for MenQuadfi meningococcal disease vaccine
Tina Tan, MD, discusses impact of FDA's stricter COVID-19 vaccine policy for children
Related Content
© 2025 MJH Life Sciences

All rights reserved.